Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-tick vaccines.

P Willadsen1

  • 1CSIRO Livestock Industries, Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, Queensland 4067, Australia. peter.willadsen@csiro.au

Parasitology
|June 9, 2005
PubMed
Summary
This summary is machine-generated.

Vaccination with protein antigens effectively combats tick infestations. Developing more potent vaccines by discovering new antigens is key to improving tick control strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental vaccination of sheep and cattle against tick infestation using recombinant 5'-nucleotidase.

Parasite immunology·2010
Same author

Control of parasitic disease using vaccines: an answer to drug resistance?

Revue scientifique et technique (International Office of Epizootics)·2007
Same author

Vaccination against ectoparasites.

Parasitology·2007
Same author

Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.

Parasite immunology·2005
Same author

Reduced oviposition of Boophilus microplus feeding on sheep vaccinated with vitellin.

Veterinary parasitology·2001
Same author

The molecular revolution in the development of vaccines against ectoparasites.

Veterinary parasitology·2001

Area of Science:

  • Veterinary Immunology
  • Parasitology
  • Vaccine Development

Background:

  • Vaccination using defined protein antigens is proven to induce immunity against tick infestation.
  • Recombinant antigens have successfully replicated this immunity, paving the way for commercial vaccine production.
  • Existing commercial tick vaccines contribute to integrated tick control strategies in field studies.

Purpose of the Study:

  • To review the current state of tick vaccine efficacy and identify avenues for improvement.
  • To discuss the role of novel vaccine antigens in enhancing protection against tick infestations.
  • To explore the potential and limitations of cross-species protection offered by tick antigens.

Main Methods:

  • Review of existing scientific literature on tick vaccination and antigen discovery.

Related Experiment Videos

  • Analysis of field study data on the efficacy of commercial tick vaccines.
  • Evaluation of the potential for new antigens to increase vaccine effectiveness.

    • Main Results:

    • Current commercial tick vaccines offer benefits within integrated control programs but often lack standalone efficacy.
    • Discovery of additional effective vaccine antigens is crucial for developing more potent tick vaccines.
    • Evidence suggests some antigens may offer cross-species protection, though mechanisms remain unclear.

    Conclusions:

    • Tick vaccines are a valuable tool but require enhanced efficacy for standalone application.
    • Continued research into novel vaccine antigens is essential for advancing tick control.
    • The potential of tick vaccine technology is significant but not yet fully realized.